Valuation: Enovis Corporation

Market Cap 1.53B 1.33B 1.24B 1.14B 2.14B 146B 2.17B 14.54B 5.71B 73.2B 5.76B 5.64B 242B P/E 2026 *
153x
P/E 2027 * 25.3x
Enterprise Value 2.75B 2.38B 2.22B 2.04B 3.83B 262B 3.89B 26.06B 10.23B 131B 10.32B 10.1B 434B EV / Sales 2026 *
1.17x
EV / Sales 2027 * 1.07x
Free-Float
98.19%
Yield 2026 *
-
Yield 2027 * -
1 day+1.14%
1 week-8.71%
Current month-8.71%
1 month+4.27%
3 months-2.35%
6 months+17.80%
Current year-0.11%
1 week 24.65
Extreme 24.65
31.66
1 month 23.32
Extreme 23.315
31.66
Current year 19.14
Extreme 19.14
31.66
1 year 19.14
Extreme 19.14
34.28
3 years 19.14
Extreme 19.14
65.03
5 years 19.14
Extreme 19.14
164.01
10 years 19.14
Extreme 19.14
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap.
30/6/26 Free

Director

846 0.0015%
31/3/26 Free

Director

770 0.0013%
7/3/26 Free

Chief Executive Officer

143,923 0.2518%
Change 5-day change 1-year change 3-year change Capi.($)
+1.14%-8.71%-6.70%-54.92% 1.53B
+0.47%+4.09%-9.92%+18.43% 130B
+1.37%-3.93%-17.22%-0.67% 12.63B
+5.28%+7.98%+104.57%+139.45% 10.61B
+2.59%-3.43%-43.52%-67.91% 4.7B
+2.93%+3.12%-22.39%+42.74% 2.7B
+2.16%+19.82%-21.92%-77.34% 1.74B
+2.82%+0.80%-14.07%-12.55% 1.69B
+2.16%-0.93%-31.19%-27.86% 1.66B
Average +2.32%+2.28%-6.93%-4.51% 18.59B
Weighted average by Cap. +1.01%+3.54%-4.70%+20.19%

Financials

2026 *2027 *
Net sales 2.34B 2.03B 1.89B 1.74B 3.26B 223B 3.32B 22.19B 8.71B 112B 8.79B 8.6B 369B 2.46B 2.13B 1.99B 1.82B 3.43B 234B 3.48B 23.3B 9.14B 117B 9.23B 9.03B 388B
Net income 6.5M 5.62M 5.25M 4.82M 9.06M 619M 9.2M 61.6M 24.18M 310M 24.41M 23.87M 1.03B 63.12M 54.6M 50.99M 46.78M 87.98M 6.01B 89.38M 598M 235M 3.01B 237M 232M 9.95B
Net Debt 1.21B 1.05B 981M 900M 1.69B 116B 1.72B 11.51B 4.52B 57.95B 4.56B 4.46B 192B 1.08B 938M 876M 804M 1.51B 103B 1.54B 10.28B 4.04B 51.75B 4.07B 3.98B 171B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
07/08/26 US$26.61 +1.14% 2,058,435
06/08/26 US$26.31 -12.82% 3,127,464
05/08/26 US$30.18 -2.20% 1,504,408
04/08/26 US$30.86 -1.78% 1,365,675
03/08/26 US$31.42 +7.79% 1,590,536
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
26.61USD
Average target price
41.33USD
Spread / Average Target
+55.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock